Local News

• CMC ICOS Biologics has big plans for former ICOS plant in Bothell  The biotechnology plant once operated by ICOS Corp. has been remodeled by its new Denmark-based owners who say they also plan to expand the staff. The 15,000-square-foot facility has been remodeled and given a new infrastructure by CMC ICOS Biologics.
  CMC ICOS Biologics July 25, 2008  
• Andreas Fibig named new chairman of Board of Management at Bayer Schering Pharma  Andreas Fibig, currently Senior VP at U.S. pharmaceuticals company Pfizer, has been appointed Chairman of the Board of Management of Bayer Schering Pharma effective September 1, 2008.
  Bayer Schering Pharma July 25, 2008  
• Applied Biosystems reports fourth quarter financial results  Applied Biosystems reported net revenues of $609.0 million for the fourth quarter of fiscal 2008, an increase of 9% over the prior year quarter of $557.3 million. The net effect of foreign currency on net revenues was a favorable impact of approximately 5% compared to the prior year quarter.
  Applied Biosystems July 24, 2008  
• Invitrogen announces second quarter 2008 financial results  Invitrogen announced results for its second quarter ended June 30, 2008. Revenues for the second quarter were $368 million, an increase of 14.3 percent over the $322 million reported for the second quarter of 2007.
  Invitrogen Corporation July 24, 2008  
• Multithreaded supercomputer seeks software for data-intensive computing  Pacific Northwest National Laboratory and Cray Inc. lead a team that received $4 million to develop software for the newest breed of supercomputers to better tackle large networks of seemingly random data, applicable in internet security, power grid stability and complex biological networks.
  Pacific Northwest National Laboratory July 24, 2008  
• Stereotaxis concludes $18 million financial arrangement with Biosense  Stereotaxis announced that it has amended its collaboration with Biosense Webster, their partner in the development of ablation catheters used with its Niobe Magnetic Navigation System. Under the amended agreement, Biosense will provide Stereotaxis $18 million.
  Stereotaxis, Inc. July 24, 2008  
• Lilly reports second-quarter results  Eli Lilly reported net income and earnings per share grew to $958.8 million in the 2008 second-quarter compared with second-quarter 2007 net income of $663.6 million. Sales increased 11 percent, to $5.150 billion.
  Eli Lilly and Company July 24, 2008  
• Albemarle to supply catalysts for commercial renewable diesel production  Albemarle Corporation has been awarded a multi-year order from Neste Oil Oyj, Finland to produce catalysts made exclusively for Neste for use in their NExBTL renewable diesel process.
  Albemarle Corporation July 23, 2008  
• Celera reports fourth quarter and fiscal 2008 results  Celera reported net revenues of $43.4 million for the fourth quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. Celera reported a net loss of $96.8 million compared to a net loss of $8.0 million for the prior year quarter.
  Celera Corporation July 23, 2008  
• Genzyme reports strong second-quarter 2008 Growth  Genzyme reported that revenue increased 25 percent to approximately $1.171 billion from $933.4 million in last year’s second quarter. Net income was $69.6 million compared with $83.8 million in the second quarter a year ago.
  Genzyme Corporation July 23, 2008  

   (next 10 articles)